KNT-CT Holdings Co., Ltd.
KNT-CT Holdings Co., Ltd. (9726.T) Financial Performance & Income Statement Overview
Analyze KNT-CT Holdings Co., Ltd. (9726.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
KNT-CT Holdings Co., Ltd. (9726.T) Income Statement & Financial Overview
View the income breakdown for KNT-CT Holdings Co., Ltd. 9726.T across both annual and quarterly reports.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $59.95B | $80.15B | $65.58B | $68.84B |
Cost of Revenue | $47.27B | $65.14B | $53.32B | $55.99B |
Gross Profit | $12.68B | $15.008B | $12.26B | $12.75B |
Gross Profit Ratio | $0.21 | $0.19 | $0.19 | $0.19 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $12.00B | $11.89B | $11.83B | $10.94B |
Operating Expenses | $12.00B | $11.89B | $11.83B | $10.94B |
Total Costs & Expenses | $59.27B | $77.03B | $65.15B | $67.03B |
Interest Income | $192.00M | $157.00M | $140.00M | $101.00M |
Interest Expense | $1.00M | -$66.00M | $13.00M | $11.00M |
Depreciation & Amortization | $144.00M | $90.25M | $110.00M | $102.00M |
EBITDA | $1.02B | $3.21B | $535.00M | $2.04B |
EBITDA Ratio | $0.02 | $0.04 | $0.008 | $0.03 |
Operating Income | $681.00M | $3.12B | $430.00M | $1.81B |
Operating Income Ratio | $0.01 | $0.04 | $0.007 | $0.03 |
Other Income/Expenses (Net) | $1.07B | $173.00M | $234.00M | $110.00M |
Income Before Tax | $1.76B | $3.29B | $664.00M | $1.92B |
Income Before Tax Ratio | $0.03 | $0.04 | $0.01 | $0.03 |
Income Tax Expense | -$376.00M | $265.00M | -$83.00M | $141.00M |
Net Income | $2.13B | $3.03B | $745.00M | $1.78B |
Net Income Ratio | $0.04 | $0.04 | $0.01 | $0.03 |
EPS | $77.96 | $110.83 | $27.27 | $65.04 |
Diluted EPS | $77.96 | $110.83 | $27.27 | $65.04 |
Weighted Avg Shares Outstanding | $27.32M | $27.32M | $27.32M | $27.32M |
Weighted Avg Shares Outstanding (Diluted) | $27.32M | $27.32M | $27.32M | $27.32M |
Over the past four quarters, KNT-CT Holdings Co., Ltd. demonstrated steady revenue growth, increasing from $68.84B in Q1 2024 to $59.95B in Q4 2024. Operating income reached $681.00M in Q4 2024, maintaining a consistent 1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.02B, reflecting operational efficiency. Net income dropped to $2.13B, with EPS at $77.96. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan